• QLT Inc. (QLTI) Slashes Workforce by Two-thirds, CEO Quits After Shareholder Coup More...

• Bristol-Myers Squibb Company (BMY) Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc. (AMLN) More...

• 23andMe, Inc. Acquires CureTogether, Inc. More...

• Janssen Pharmaceutica N.V. Enters Alliance With CureBeta for Up to $308 Million More...

• Swedish Orphan Biovitrum Enters Research Collaboration With Affibody Within the IL-1 Field More...

• Noble Life Sciences Inc. Announces Collaboration With Perseis Therapeutics -- Noble to Manage Neuren Pharmaceuticals Limited Subsidiary's Oncology Program More...

• Galenea and Eisai Company, Ltd. (ESALY.PK) Enter into Research Collaboration to Develop Synaptic Modulators for Neurodegenerative Diseases More...

• Ablexis Announces Licensing of the AlivaMab Mouse Technology to Another Major Pharmaceutical Company More...

• BioNeutral Appoints Mr. Mark Lowenthal as Chief Executive and President More...

• Jeff Cooper Joins KaloBios Pharmaceuticals, Inc. as Chief Financial Officer More...

• Dynavax Technologies Corporation (DVAX) AppointsDavid Happel Vice President, Global Sales and Marketing More...

• William M. McClements Joins Merrimack Pharmaceuticals Inc. as Senior Vice President of Corporate Operations More...

• New Vice President at Vitrolife More...

• Furiex Pharmaceuticals, Inc. (FURX) Announces Second Quarter 2012 Earnings Release and Conference Call More...

• IMPAX Laboratories, Inc. (IPXL) Schedules Conference Call and Webcast for Second Quarter 2012 Financial Results More...

• Peregrine Pharmaceuticals, Inc. (PPHM) to Report Fourth Quarter and Fiscal Year 2012 Financial Results After Market Close on July 16, 2012 More...

• Simulations Plus (SLP) Sets Date for 3rd Quarter 2012 Earnings Release and Conference Call More...

• Bristol-Myers Squibb Company (BMY) Announces Humacao Site Expansion More...

• CRI Lifetree Opens New Early Stage Research Facility More...

• Merck & Co., Inc. (MRK) Accused of Lying About Vaccine Effectiveness More...

• TiGenix Enrolls First Patients in Pivotal Phase III Trial With Lead Product Cx601 in Perianal Fistulas More...

• Eisai Inc. (ESALF.PK) Announces Preliminary Results of Phase III Study of Halaven&#0174 (eribulin mesylate) Injection in Locally Advanced or Metastatic Breast Cancer More...

• Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B More...

• Nymox Pharmaceutical (NYMX) Announces Positive Safety Monitoring Committee Results for Phase 3 BPH NX02-0020 Repeat Injection U.S. Study More...

• Sanofi (France) (SAN.PA) Pulls Filings for Anticoagulant Mulsevo More...

• Human Genome Sciences, Inc. (HGSI) Announces Resubmission of Raxibacumab BLA to FDA More...

• Acella Pharmaceuticals, LLC, files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration for Topical Corticosteroids Lotion More...

• Vitrolife: Application for Market Approval of STEEN Solution™ in the USA Has Been Submitted to the FDA More...

• Sitting Less Could Extend Your Life, Pennington Biomedical Research Center Study More...

• Handlebar Level Can Affect Sexual Health of Female Cyclists, Yale University School Of Medicine Study More...

• Obesity Linked to Circle of Friends, Loyola University Chicago Stritch School of Medicine Study More...

• More Proof Cranberry Juice Thwarts Infection, National Taiwan University Hospital Study More...

• Facebook Use Leads to Depression? University of Wisconsin Study More...

• ImmunoCellular Therapeutics, Ltd' Brain Cancer Technology Receives Important Japanese Patent Allowance More...

• A.P. Pharma, Inc. (APPA) Announces the Allowance of Three Patents Covering APF530 More...

• Sanofi (France) (SAN.PA)'s Sleep Driving Drug Should Remain on the Shelves Says Australian Therapeutic Goods Administration More...